Cargando…
New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc
The molecular determinants of Alzheimer's (AD) disease are still not completely known; however, in the past two decades, a large body of evidence has indicated that an important contributing factor for the disease is the development of an unbalanced homeostasis of two signaling cations: calcium...
Autores principales: | Corona, C, Pensalfini, A, Frazzini, V, Sensi, S L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168999/ https://www.ncbi.nlm.nih.gov/pubmed/21697951 http://dx.doi.org/10.1038/cddis.2011.57 |
Ejemplares similares
-
Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies
por: Pires, Mariana, et al.
Publicado: (2023) -
Altered Kv2.1 functioning promotes increased excitability in hippocampal neurons of an Alzheimer's disease mouse model
por: Frazzini, V, et al.
Publicado: (2016) -
Wnt Signaling Deregulation in the Aging and Alzheimer’s Brain
por: Palomer, Ernest, et al.
Publicado: (2019) -
Effects of non-pharmacological or pharmacological interventions on cognition and brain plasticity of aging individuals
por: Pieramico, Valentina, et al.
Publicado: (2014) -
Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential
por: Immanuel, Tracey, et al.
Publicado: (2022)